In Washington, D.C., the Holland & Knight Health Dose provides a weekly dose of legislative and regulatory insights to keep stakeholders informed about developments in the health sector. This week’s topics cover a wide range of issues, including bipartisan efforts in the Senate Finance Committee to draft a GME bill, legislation to prohibit biotechnology contracting with foreign adversaries, and a resolution filed by Sen. Paul on Laboratory Developed Tests.
Other highlights include the formation of a new Preventive Health Caucus, updates on congressional retirements and resignations, FDA guidance on AI to address data quality and transparency, an equitable and affordable access proposal and RFI from NIH, a guidance reversal from OCR, and CMS’s Oncology Model Expansion.
In addition to these updates, Congress members are advocating for expanded coverage of digital therapeutics, a bipartisan group of legislators in the E&C Health Subcommittee have introduced 340B legislation, and Rep. Pallone has requested a report on prior authorization from the GAO. The Senate HELP Committee has also approved six measures, and there have been House hearings on healthcare consolidation.
To stay informed on these important health sector updates, be sure to check out the complete content of the Holland & Knight Health Dose.
